SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Biotechnology Cancer Cures

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (42)4/26/1999 8:18:00 PM
From: Biotech Jim  Read Replies (1) of 226
 
Further reading about the difficulty in cancer trials and the trials that resulted in the FDA approval of Genentech's Herceptin:

Her 2: The making of Herceptin, a revolutionary treatment for breast cancer, by Robert Bazell

All in all, a pretty good and quick read. Most people reading this thread realize that Herceptin is a humanized mAb that is successful in treating her-2/neu overexpressing breast cancers.

BJ
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext